Prawo i regulacje · 30/10/2020

US FDA Approves Oliceridine for Placement in Schedule II of Controlled Substances Act

The US FDA approved a new drug application for oliceridine, a medication that will be placed in Schedule II of the Controlled Substances Act, following a recommendation from the Department of Health and Human Services to the DEA.